Announcements
9 August 2023
MDPI World Hepatitis Day Webinar 2023, Held on 28 July 2023
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
To commemorate the World Hepatitis Day 2023, MDPI organized a webinar on 28 July 2023 to encourage researchers to come together, take action, and highlight how the exchange of findings facilitates efforts to raise awareness of hepatitis. The low coverage of testing and treatment is the most important gap to be addressed to achieve the global elimination goals of hepatitis B virus (HBV) by 2030.
Speaker/Presentation |
Introduction |
Prof. Dr. Chia-Yen Dai Achieving Elimination of Hepatitis C in Taiwan |
Dr. Tan Yee Joo Understanding the Functions of Hepatitis B Viral Proteins and Targeting Them in Antiviral Drug Development |
Dr. Sheikh Mohammad Fazle Akbar Standing at the Half-Way: An Analysis of “Elimination of Hepatitis by 2030” in Developed and Developing Countries |
Q&A Session |
You can watch the recorded webinar below:
Speaker/Presentation |
Introduction |
Prof. Dr. John Tavis The International Coalition to Eliminate HBV (ICE-HBV): Promoting Global Scientific Collaboration in HBV Cure Research |
Prof. Dr. Mark A. Feitelson Microbial Metabolites that Attenuate the Pathogenesis of Cancer and Autoimmunity |
Prof. Dr. Natalia Osna Hepatitis in HIV Infection |
Q&A Session |
You can watch the recorded webinar below:
Relevant Special Issues:
Pathogens
“Research on Hepatitis B Virus: Past, Present, and Future”
Edited by: Hyung Joon Yim
Submission deadline: 31 August 2023
JPM
“Novel Challenges and Therapeutic Options for Liver Diseases”
Edited by: Guido Gerken
Submission deadline: 30 September 2023
Medicina
“Viral Hepatitis Research: Updates and Challenges”
Edited by: Endrit Shahini, Antonio Giovanni Solimando and Antonella Argentiero
Submission deadline: 15 October 2023
Cells
“Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis: Molecular and Multicellular Control of Evolving Diseased States”
Edited by: Jérôme Eeckhoute
Submission deadline: 15 February 2024
Diagnostics
“Diagnosis and Management of Liver Diseases—2nd Edition”
Edited by: Jeong-Ju Yoo
Submission deadline: 30 September 2023
Vaccines
“Vaccination and Treatments against Viral Hepatitis: Achievements, Challenges and Perspectives”
Edited by: Bárbara Vieira Do Lago and Vinicius M. Mello
Submission deadline: 15 October 2023